Topics

Glioblastoma | Treatment | Targeted therapy | Overview

Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Overview

Shikalov A, Koman I, Kogan NM.
Targeted Glioma Therapy-Clinical Trials and Future Directions.
Pharmaceutics. 2024 Jan 11;16(1):100. doi: 10.3390/pharmaceutics16010100. PMID: 38258110. Review. ˍ

Jacome MA, Wu Q, Piña Y, Etame AB.
Evolution of Molecular Biomarkers and Precision Molecular Therapeutic Strategies in Glioblastoma.
Cancers (Basel). 2024 Oct 29;16(21):3635. doi: 10.3390/cancers16213635. PMID: 39518074. Review. ˍ

Satish S, Athavale M, Kharkar PS.
Targeted therapies for Glioblastoma multiforme (GBM): State-of-the-art and future prospects.
Drug Dev Res. 2024 Nov 1;85(7):e22261. doi: 10.1002/ddr.22261. PMID: 39485272. Review˰ ˍ

Rusak A, Wiatrak B, Krawczyńska K, Górnicki T, Zagórski K, Zadka Ł, Fortuna W.
Starting points for the development of new targeted therapies for glioblastoma multiforme.
Transl Oncol. 2024 Nov 11;51:102187. doi: 10.1016/j.tranon.2024.102187. PMID: 39531784. Review. ˍ

Ippen FM, Scherm A, Kessler T, Hau P, Agkatsev S, Baurecht H, Wick W, Knüttel H, Leitzmann MF, Seliger-Behme C.
Targeted agents in patients with progressive glioblastoma-A systematic meta-analysis of randomized clinical trials.
Cancer Med. 2024 Jun 21;13(12):e7362. doi: 10.1002/cam4.7362. PMID: 39618405. Meta-analysis. ˍ

Singh G, Rohit, Kumar P, Aran KR.
Targeting EGFR and PI3K/mTOR pathways in glioblastoma: innovative therapeutic approaches.
Med Oncol. 2025 Mar 10;42(4):97. doi: 10.1007/s12032-025-02652-1. PMID: 40064710. Review˰ ˍ